Jefferies Files 424B2 Prospectus for Securities Offering

TL;DR

**Jefferies is prepping to issue new securities, watch for potential dilution.**

AI Summary

Jefferies Financial Group Inc. filed a 424B2 prospectus on March 25, 2026, related to a previous registration statement (File No. 333-271881). This filing is a standard update for offering securities, indicating that Jefferies is likely preparing to issue new shares or debt. For current or potential shareholders, this matters because new offerings can dilute existing shares or increase the company's debt load, potentially impacting stock value and future earnings per share.

Why It Matters

This filing signals Jefferies' intent to offer new securities, which could impact shareholder value through dilution or increased leverage.

Risk Assessment

Risk Level: medium — The filing itself is routine, but the underlying potential for new security issuance carries medium risk due to possible dilution or increased debt.

Analyst Insight

Investors should monitor Jefferies' subsequent filings for details on the type, size, and terms of the securities offering to assess potential impact on share price and ownership.

Key Numbers

• 424B2 — Form Type (Indicates a prospectus for a securities offering)
• 2026-03-25 — Filing Date (The date Jefferies submitted this prospectus)
• 333-271881 — File No. (The registration statement number this prospectus relates to)

Key Players & Entities

• Jefferies Financial Group Inc. (company) — the filer of the 424B2 prospectus
• 0000096223 (company) — the CIK of Jefferies Financial Group Inc.
• 2026-03-25 (date) — the filing date of the 424B2 prospectus
• 333-271881 (dollar_amount) — the File No. for the related registration statement

Forward-Looking Statements

• Jefferies Financial Group Inc. will proceed with a securities offering. (Jefferies Financial Group Inc.) — high confidence, target: 2026-12-31

FAQ

Key Financial Figures

• $1,000 — e not required to do so. Issue Price: $1,000 per Note Stated Principal Amount: $1,
• $33.13 — will pay a Contingent Coupon Payment of $33.13 on the applicable Coupon Payment Date i
• $975.20 — lue on the Pricing Date: Approximately $975.20 per Note, or within $30.00 of that esti
• $30.00 — proximately $975.20 per Note, or within $30.00 of that estimate. Please see "The Notes
• $8.00 — uer will pay a structuring fee of up to $8.00 per Note in connection with the distrib
• $975 — the Pricing Date will be approximately $975.20, or within $30.00 of that estimate.
• $0.00 — per Note Return on the Notes 0.00 $0.00 -100.00% 50.00 $500.00 -50.00% 74.
• $500.00 — he Notes 0.00 $0.00 -100.00% 50.00 $500.00 -50.00% 74.99 $749.90 -25.01% 75.0
• $749.90 — 00.00% 50.00 $500.00 -50.00% 74.99 $749.90 -25.01% 75.00 (1) $1,033.13 3.313%
• $1,033.13 — % 74.99 $749.90 -25.01% 75.00 (1) $1,033.13 3.313% 80.00 $1,033.13 3.313% 90.0

Filing Documents

• ef20068654_424b2.htm (424B2) — 266KB
• image1.jpg (GRAPHIC) — 153KB
• image2.jpg (GRAPHIC) — 165KB
• image3.jpg (GRAPHIC) — 159KB
• image.jpg (GRAPHIC) — 11KB
• 0001140361-26-011027.txt ( ) — 940KB

RISK FACTORS

RISK FACTORS PS-6 THE UNDERLYINGS PS-11 HEDGING PS-19 SUPPLEMENTAL DISCUSSION OF U.S. FEDERAL INCOME TAX CONSEQUENCES PS-20 SUPPLEMENTAL PLAN OF DISTRIBUTION PS-25 CONFLICT OF INTEREST PS-30 LEGAL MATTERS PS-31 EXPERTS PS-32 You should rely only on the information contained in or incorporated by reference in this pricing supplement and the accompanying product supplement, prospectus and prospectus supplement. We have not authorized anyone to provide you with different information. We are not making an offer of these securities in any state where the offer is not permitted. You should not assume that the information contained in this pricing supplement or the accompanying product supplement, prospectus or prospectus supplement is accurate as of any date later than the date on the front of this pricing supplement. PS-i Table of Contents SPECIAL NOTE ON FORWARD-LOOKING STATEMENTS This pricing supplement and the accompanying product supplement, prospectus and prospectus supplement contain or incorporate by reference "forward-looking statements" within the meaning of the safe harbor provisions of Section 27A of the Securities Act of 1933 (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are not statements of historical fact and represent only our belief as of the date such statements are made. There are a variety of factors, many of which are beyond our control, which affect our operations, performance, business strategy and results and could cause actual reported results and performance to differ materially from the performance and expectations expressed in these forward-looking statements. These factors include, but are not limited to, financial market volatility, actions and initiatives by current and future competitors, general economic conditions, controls and procedures relating to the close of the quarter, the effects of current, pending and future legislation or rulemaking

RISK FACTORS

RISK FACTORS In addition to the other information contained and incorporated by reference in this pricing supplement and the accompanying product supplement, prospectus and prospectus supplement, including the section entitled "Risk Factors" in our Annual Report on Form 10K, you should consider carefully the following factors before deciding to purchase the Notes. Structure-related Risks You may lose a significant portion or all of your investment. If the Final Value of the Worst-Performing Underlying is less than its Threshold Value, you will receive for each Note that you hold a Payment at Maturity that is less than the Stated Principal Amount of each Note. In this case investors will lose 1% of the Stated Principal Amount for every 1% decline in the Final Value below the Initial Value. Investors may lose up to 100% of the Stated Principal Amount of the Notes. Your investment return is limited to the return represented by the Contingent Coupon Payments, if any. Your investment return will be limited to the return represented by the Contingent Coupon Payments, if any, paid over the term of the Notes. You will not receive a payment on the Notes greater than the Stated Principal Amount plus any Contingent Coupon Payments, regardless of the appreciation of the Underlyings. In contrast, a direct investment in the Underlyings (or any securities, commodities or other assets represented by the Underlyings) would allow you to receive the full benefit of any appreciation in the value of the Underlyings (or those underlying assets). You may not receive any Contingent Coupon Payments. You will not necessarily receive any Contingent Coupon Payments on the Notes. If the Observation Value of the Worst-Performing Underlying is less than its Coupon Barrier on each Coupon Observation Date, you will not receive any Contingent Coupon Payments over the term of the Notes. In this case, you will not receive a positive return on the Notes. If the Notes are called you will be s

View Full Filing

View this 424B2 filing on SEC EDGAR